Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review
Sodium-glucose cotransporter 2 inhibitors (SGLT-2) are a new class of hypoglycemic drugs that were initially approved for the treatment of type 2 diabetes. Currently, 5 drugs in the SGLT-2 class of drugs are approved by the FDA for glycemic control: canagliflozin, dapagliflozin, empagliflozin, ertug...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |